Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 10
2003 5
2004 13
2005 13
2006 11
2007 10
2008 12
2009 14
2010 15
2011 19
2012 14
2013 26
2014 13
2015 20
2016 23
2017 19
2018 28
2019 25
2020 30
2021 31
2022 18
2023 13
2024 13
2025 15
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

370 results

Results by year

Filters applied: . Clear all
Page 1
Integrating genetic and imaging information to enhance cardiovascular risk stratification: rationale and design of the CVRISK-IT randomised controlled trial.
Di Angelantonio E, Piepoli M, Castelvecchio S, Barberio C, Chiarello C, Cerri A, Boveri S, Cardani R, Ambrogi F, Guelfi S, Baldassarre D, Colombo G, Amato M, Baetta R, Arbustini E, Liuzzo G, Kaptoge S, Severino A, Ferrante G, La Rovere MT, Parati G, Pengo MF, Latini R, Roncaglioni MC, Rigoni M, De Curtis A, Frati L, Ameri P, Camici PG, Volpe M, Menicanti L. Di Angelantonio E, et al. Among authors: latini r. Eur Heart J Qual Care Clin Outcomes. 2026 Mar 4:qcag032. doi: 10.1093/ehjqcco/qcag032. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2026. PMID: 41778587
Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial.
Rossello X, Barrabés JA, Piepoli M, Dominguez-Rodriguez A, Sánchez PL, Anguita M, Raposeiras-Roubín S, Grigis G, Agüero J, Owen R, Pocock S, Pérez-García CN, Escalera N, Kallmeyer A, Sionis A, Staszewsky L, Torres A, Barquero R, Fernández-Vazquez F, Marín F, Vetrano A, Pastor P, Fuster V, Latini R, Ibanez B. Rossello X, et al. Among authors: latini r. Eur Heart J Cardiovasc Pharmacother. 2026 Feb 27;12(2):64-74. doi: 10.1093/ehjcvp/pvag002. Eur Heart J Cardiovasc Pharmacother. 2026. PMID: 41564893 Free PMC article. Clinical Trial.
Beta-Blockers after Myocardial Infarction. Reply.
Ibanez B, Latini R, Rossello X. Ibanez B, et al. Among authors: latini r. N Engl J Med. 2026 Feb 19;394(8):823-824. doi: 10.1056/NEJMc2518019. N Engl J Med. 2026. PMID: 41707154 No abstract available.
Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
Rossello X, Dominguez-Rodriguez A, Latini R, Sánchez PL, Raposeiras-Roubín S, Anguita M, Barrabés JA, Grigis G, Owen R, Pocock S, Gómez-Talavera S, García-Lunar I, Escalera N, Pérez-García CN, Di Fusco SA, Pizarro G, López Benito M, Pongetti G, Rincón-Díaz LM, Buera I, Rozado J, García MJ, Prada-Delgado O, Cosmi D, Fuster V, Ibanez B. Rossello X, et al. Among authors: latini r. Eur Heart J. 2026 Feb 11;47(6):701-715. doi: 10.1093/eurheartj/ehaf673. Eur Heart J. 2026. PMID: 40884211 Clinical Trial.
Natural history of familial cerebral cavernous malformations: the CCM_Italia cohort study.
Lanfranconi S, Scola E, Novelli D, Poggesi A, Pescini F, Pavanello M, Romano F, D'Alessandris QG, Marani W, Signorelli F, Iaconetta G, Torelli G, Fainardi E, Severino M, Remore LG, Bertani GA, Conte G, Capra V, Vasamì A, Nicolis E, Contino G, Ronchi D, Palmieri MC, Previtali A, Mattogno PP, Sturiale CL, Solarino ME, Caliulo R, Bozzi MT, Fratini F, Zanier ER, Latini R, Meessen JMTA, Locatelli M; and the CCM_Italia investigators. Lanfranconi S, et al. Among authors: latini r. Front Neurol. 2026 Jan 5;16:1668098. doi: 10.3389/fneur.2025.1668098. eCollection 2025. Front Neurol. 2026. PMID: 41561324 Free PMC article.
Effect of beta blocker withholding or withdrawal after myocardial infarction without reduced ejection fraction on ischaemic events: a post hoc analysis from the REBOOT trial.
Rossello X, Sánchez PL, Owen R, Raposeiras-Roubín S, Poletti F, Barrabés JA, Anguita M, Dominguez-Rodriguez A, Lombardi M, Pocock S, Díez-Villanueva P, Vives-Borrás M, Rollán MJ, D'Orazio S, Escalera N, Isabel-Santos A, Chiampan A, de Diego O, López-Benito M, Moreno E, Rincón-Díaz LM, París H, Latini R, Fuster V, Ibanez B. Rossello X, et al. Among authors: latini r. EuroIntervention. 2025 Dec 1;21(23):e1434-e1444. doi: 10.4244/EIJ-D-25-00826. EuroIntervention. 2025. PMID: 40887991 Free article. Clinical Trial.
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.
Ibanez B, Latini R, Rossello X, Dominguez-Rodriguez A, Fernández-Vazquez F, Pelizzoni V, Sánchez PL, Anguita M, Barrabés JA, Raposeiras-Roubín S, Pocock S, Escalera N, Staszewsky L, Pérez-García CN, Díez-Villanueva P, Pérez-Rivera JA, Prada-Delgado O, Owen R, Pizarro G, Caldes O, Gómez-Talavera S, Tuñón J, Bianco M, Zarauza J, Vetrano A, Campos A, Martínez-Huertas S, Bueno H, Puentes M, Grigis G, Bonilla-Palomas JL, Marco E, González-Juanatey JR, Bangueses R, González-Juanatey C, García-Álvarez A, Ruiz-García J, Carrasquer A, García-Rubira JC, Pascual-Figal D, Tomás-Querol C, San Román JA, Baratta P, Agüero J, Martín-Reyes R, Colivicchi F, Ortas-Nadal R, Bazal P, Cordero A, Fernández-Ortiz A, Basso P, González E, Poletti F, Bugani G, Debiasio M, Cosmi D, Navazio A, Bermejo J, Tortorella G, Marini M, Botas J, de la Torre-Hernández JM, Ottani F, Fuster V; REBOOT-CNIC Investigators. Ibanez B, et al. Among authors: latini r. N Engl J Med. 2025 Nov 13;393(19):1889-1900. doi: 10.1056/NEJMoa2504735. Epub 2025 Aug 30. N Engl J Med. 2025. PMID: 40888702 Clinical Trial.
Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.
Kristensen AMD, Rossello X, Atar D, Yndigegn T, Kimura T, Latini R, Lindahl B, Halvorsen S, Olsen MH, Fuster V, Hofmann R, Vikenes K, Maeng M, Erlinge D, Pocock S, Karlström P, Bakken A, Lange T, Barrabés JA, Benatar J, Raposeiras-Roubin S, Held C, Piepoli M, Fagerland MW, Holmager T, Ozasa N, Prescott EIB, Munkhaugen J, Jernberg T, Ibanez B; Beta-Blocker Trialists’ Collaboration Study Group.. Kristensen AMD, et al. Among authors: latini r. N Engl J Med. 2025 Nov 9. doi: 10.1056/NEJMoa2512686. Online ahead of print. N Engl J Med. 2025. PMID: 41211954
370 results